Yeonsu-gu
Incheon Gwang'yeogsi
Samsung Bioepis
is a South Korea-based biopharmaceutical company that develops and commercializes biosimilar medicines... Read moreSamsung Bioepis
is a South Korea-based biopharmaceutical company that develops and commercializes biosimilar medicines... Read moreNews
Partnership
Mar 19, 2025
Korea Biomedical Review
Samsung Bioepis partners with Hanmi for Prolia biosimilar as Celltrion cuts price
investment
Mar 12, 2025
https://www.businesswire.com/news/home/20250313842642/en/Samsung-Invests-in-C2N-Diagnostics
Samsung Bioepis Co., Ltd. has invested $10M in C2N Diagnostics, LLC
Leadership Change
Nov 28, 2024
The Business Times
Kyung-ah Kim is now President & CEO at Samsung Bioepis
Samsung Bioepis Competitors
1
2
3
4
5
6
7
8
9
10